Tidswell R, Owen C, Shafey M, Perry S, et al. Real-World Selection of Venetoclax-Obinutuzumab Versus BTK Inhibitor Therapy for Treatment-Naive Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. Eur J Haematol 2026 Feb 16. doi: 10.1111/ejh.70137.
PMID: 41698679